Judge Denies Request To Dismiss Patent Challenge Vs. Glaxo's AZT

Law360, New York (May 3, 2004, 12:00 AM EDT) -- A federal judge has refused to throw out a challenge filed by the largest AIDS group in the U.S. against GlaxoSmithKline’s patent for AZT (Retrovir), the first AIDS drug.

Late last week, the U.S. District Court for the Central District of California Western Division rejected GlaxoSmithKline's motion for summary judgment against AIDS Healthcare Foundation's (AHF) patent piracy lawsuit.

The ruling sustains AHF's federal court case over the patent for AZT and other subsequent derivative AIDS drugs, the non-profit group said in a statement.

The AZT patent...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.